$2.78
-0.04[-1.42%]
At close: Mar 22
$2.78
0[0.00%]
After Hours: 9:00AM EDT
Lumos Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lumos Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/01/2024 | PM | LUMO | Q1 | -$0.89 | -$1.01 | — | — | $691.00K | — | — | — | Get Alert |
03/07/2024 | PM | LUMO | Q4 | -$0.98 | -$1.15 | -$1.17 | -1.74% | $512.00K | — | $826.00K | — | Get Alert |
11/07/2023 | PM | LUMO | Q3 | -$0.86 | -$1.15 | -$1.04 | 9.57% | $497.00K | $320.00K | $7.00K | -97.81% | Get Alert |
08/09/2023 | PM | LUMO | Q2 | -$0.94 | -$1.10 | -$1.09 | 0.91% | $403.00K | $410.00K | $527.00K | 28.54% | Get Alert |
05/03/2023 | PM | LUMO | Q1 | -$0.92 | -$1.12 | -$0.89 | 20.54% | $111.00K | $180.00K | $691.00K | 283.89% | Get Alert |
03/01/2023 | PM | LUMO | Q4 | -$0.68 | -$0.93 | -$0.98 | -5.38% | $220.00K | $110.00K | $512.00K | 365.45% | Get Alert |
11/14/2022 | AM | LUMO | Q3 | -$0.90 | -$1.01 | -$0.86 | 14.85% | $0.00 | $60.00K | $497.00K | 728.33% | Get Alert |
08/09/2022 | PM | LUMO | Q2 | -$1.04 | -$0.99 | -$0.94 | 5.05% | $10.00K | $20.00K | $403.00K | 1915.00% | Get Alert |
05/10/2022 | PM | LUMO | Q1 | -$1.04 | -$0.89 | -$0.92 | -3.37% | $0.00 | — | $111.00K | — | Get Alert |
03/10/2022 | PM | LUMO | Q4 | -$0.31 | -$0.92 | -$0.68 | 26.09% | $40.00K | — | $220.00K | — | Get Alert |
11/03/2021 | PM | LUMO | Q3 | $0.21 | -$1.07 | -$0.90 | 15.89% | $74.00K | — | $0.00 | — | Get Alert |
08/05/2021 | AM | LUMO | Q2 | -$0.65 | -$1.04 | -$1.04 | 0.00% | $33.00K | — | $10.00K | — | Get Alert |
05/05/2021 | PM | LUMO | Q1 | -$0.14 | -$0.87 | -$1.04 | -19.54% | $21.00K | — | $0.00 | — | Get Alert |
03/09/2021 | PM | LUMO | Q4 | — | -$0.86 | -$0.31 | 63.95% | — | $10.00K | $40.00K | 300.00% | Get Alert |
11/10/2020 | PM | LUMO | Q3 | — | -$0.64 | $0.21 | 132.81% | — | — | $74.00K | — | Get Alert |
08/13/2020 | PM | LUMO | Q2 | -$2.47 | — | -$0.65 | — | — | — | $33.00K | — | Get Alert |
05/28/2020 | PM | LUMO | Q1 | — | -$0.82 | -$0.14 | 82.93% | — | — | $21.00K | — | Get Alert |
Lumos Pharma (LUMO) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $-1.17, which missed the estimate of $-1.15.
The Actual Revenue was $826K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.